US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist
  • 22.970
  • -0.500-2.13%
Close Dec 13 16:00 ET
  • 22.488
  • -0.483-2.10%
Post 18:19 ET
3.31BMarket Cap-8.32P/E (TTM)

Denali Therapeutics Key Stats

Denali Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.000M--
--2024/Q4-- / 12.583M--
--2024/Q30.000 / 8.357M--
--2024/Q20.000 / 10.773M--
--2024/Q10.000 / 13.022M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.000M--
--2024/Q4-- / 12.583M--
--2024/Q30.000 / 8.357M--
--2024/Q20.000 / 10.773M--
--2024/Q10.000 / 13.022M--

Unlock Free Earnings Estimates

Denali Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 13, 2024

Strong Buy

  • Buy

    83.33%
  • Hold

    16.67%
  • Sell

    0.00%

Price Target

No Data